Sequence BioDiscovering the true signals of disease to power life-changing drugs.

Sequence Bio: Discovering True Signals of Disease

Introduction

Sequence Bio is revolutionizing drug target discovery by leveraging the unique genetic makeup of Newfoundland and Labrador. Our mission is to identify the true signals of disease to accelerate the development of life-changing medicines.

Key Features

• Founder Effect: Less biological variation enables efficient identification of low-frequency, high-impact variants.
• Complete Health Records: Consistent phenotypic stratification to uncover new links between variants and disease.
• Integrated Systems Biology: Combines multi-omics, real-world patient data, and well-characterized phenotypes.
• Custom Discovery Cohorts: Tailored for both common and rare disease indications.

Use Cases

• Pharmaceutical R&D: Partnering with leading pharma and biotech companies to shorten R&D timelines.
• Genetic Research: Utilizing the NL Genome Project to study the genetic makeup of 10,000 participants.
• Disease Prevention: Improving treatment and prevention strategies through better target discovery.

Pricing

Sequence Bio offers customized pricing based on the specific needs of our partners. Contact us for detailed pricing information tailored to your research and development requirements.

Teams

Our team comprises local and global experts dedicated to improving health outcomes with better medicines, faster. We are guided by a scientific advisory board of the brightest minds and a committed leadership team.

• Leadership Team: Includes experts in policy, strategy, data science, security, research, medical partnerships, and human resources.
• Scientific Advisory Board: Features renowned professionals from institutions like Stanford Medicine and Auransa Inc.
• Board of Directors: Comprises experienced leaders from Killick Capital, Columbus Capital, and Klister Credit Corp.

Join us in our mission to transform drug discovery and improve health outcomes. We're hiring—become part of our innovative team.